Does Dr. Abi-Rached study colorectal cancer?

Yes, Dr. Abi-Rached studies the occurrence of adenomas in patients who have had surgery for colorectal cancer.

What are adenomas, and why should I be concerned about them after colon surgery?

Adenomas are benign growths that can develop after colon surgery. They can lead to further complications, including the risk of new colon cancer, which is why regular check-ups are important.

Is Dr. Abi-Rached's research relevant for patients with gallbladder cancer?

Yes, his research addresses the challenges of diagnosing and managing gallbladder cancer, highlighting the need for better treatment options.

DR. BASSAM ABI-RACHED, M.D.

ALEXANDRIA, LA

Research Active

Internal Medicine - Hematology & Oncology NPI registered 21+ years 3 publications 1995 – 1996 NPI: 1285637314

Internal Medicine - Hematology & Oncology

Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Incidence Disease-Free Survival Colorectal Neoplasms Survival Rate Adenocarcinoma Kidney Neoplasms Carcinoma, Renal Cell Colonoscopy Colonic Polyps Adenomatous Polyps Neoplasms, Second Primary Clinical Trials, Phase II as Topic Drug Resistance

Practice Location

605B MEDICAL CENTER DR
ALEXANDRIA, LA 71301-8127

Phone: (318) 442-2232

What does BASSAM ABI-RACHED research?

Dr. Abi-Rached studies the occurrence of adenomas, which are benign tumors that can develop after surgery for colorectal cancer. He found that about 30% of patients who have undergone surgery for colon cancer develop at least one adenoma, with many cases appearing within the first two years. This research emphasizes the importance of regular check-ups for early detection to prevent the risk of new colon cancer. Additionally, he investigates gallbladder carcinoma, a rare but serious cancer affecting a small number of individuals each year. His research shows that most patients are diagnosed at an advanced stage, limiting treatment options and survival rates. Dr. Abi-Rached's work underscores the urgent need for improved detection and management strategies for this type of cancer.

Key findings

30% of colorectal cancer surgery patients develop adenomas, with some having more than five adenomas within two years post-surgery.
Gallbladder cancer affects only 2.2 to 4.4 people per 100,000 in the U.S., making early detection crucial.
Only 16% of gallbladder cancer cases are operable, and fewer than 5% survive five years after diagnosis.

Frequently asked questions

Does Dr. Abi-Rached study colorectal cancer?: Yes, Dr. Abi-Rached studies the occurrence of adenomas in patients who have had surgery for colorectal cancer.
What are adenomas, and why should I be concerned about them after colon surgery?: Adenomas are benign growths that can develop after colon surgery. They can lead to further complications, including the risk of new colon cancer, which is why regular check-ups are important.
Is Dr. Abi-Rached's research relevant for patients with gallbladder cancer?: Yes, his research addresses the challenges of diagnosing and managing gallbladder cancer, highlighting the need for better treatment options.

Publications in plain English

Incidence of adenomas after curative resection for colorectal cancer.

1996

The American journal of gastroenterology

Neugut AI, Lautenbach E, Abi-Rached B, Forde KA

Plain English
This study looked at patients who had surgery for colon cancer to see how often they develop new growths called adenomas afterward. Out of 351 patients, 87 (30%) had at least one adenoma, with some having more than five, and most of these cases were found within two years after surgery. This finding is important because regular check-ups can help catch these growths early, potentially reducing the risk of new colon cancer. Who this helps: This helps patients who have had colorectal cancer surgery.

PubMed

Diagnostic and management issues in gallbladder carcinoma.

1995

Oncology (Williston Park, N.Y.)

Abi-Rached B, Neugut AI

Plain English
This study looked at gallbladder cancer, which is quite rare, affecting only 2.2 to 4.4 people out of every 100,000 in the U.S. The findings revealed that most patients are diagnosed late when the cancer is advanced, and only 16% of cases can be treated successfully with surgery. Unfortunately, fewer than 5% of patients survive five years after diagnosis, highlighting the need for better detection and treatment options. Who this helps: This information benefits patients and doctors by raising awareness of the challenges in diagnosing and managing gallbladder cancer.

PubMed

Chemotherapy for advanced renal-cell carcinoma: 1983-1993.

1995

Seminars in oncology

Yagoda A, Abi-Rached B, Petrylak D

PubMed

Frequent Co-Authors

A I Neugut E Lautenbach K A Forde A Yagoda D Petrylak

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.